Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Summit Technology (BEAM) -- Ignore unavailable to you. Want to Upgrade?

To: Joe who wrote (1186)	4/11/1999 8:50:00 PM
From: Walter in HK	Read Replies (1) \| Respond to of 1386

Joe, Paul Kelly's question was ...the age related need for reading (magnifying) glasses was not procedurally correctable. I take it from your answer that when the lens hardens at age 40 - 45 one is called a presbyope (I had Greek = old) and when it occurs earlier, it is called hyperopia. Are they then both equally treatable ? I do notice you are favorably impressed by SNRS and I notice in their 10K or 424 SEC Form that they specifically mention presbyopia. Do they look at that market in particular ? Does one need a separate FDA approval for Presbyopia ? I am not in the field, but from your answer, it being the (same ?) phenomenon of hardening of the lens, I would guess, no separate FDA approval is needed. Kindly clarify. Walter in HK